alphaveVINEETLAB₹36.00

Vineet Laboratories Limited

₹ CrorePeersBIOFILCHEM MANGALAM LASA KREBSBIO ALPA BALPHARMA ORTINGLOBE NATCAPSUQMcap ₹69.2 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	26.9	25.5	24.2
+ Investments (Equity Method)	—	0.2	0.0
+ Non-current Investments	0.2	0.0	0.2
+ Long-term Loans	0.0	0.0	0.8
+ Other Non-current Financial Assets	1.6	0.8	0.7
Non-current Financial Assets	1.8	0.8	1.7
+ Other Non-current Assets	—	0.7	0.0
Total Non-current Assets	28.7	27.1	26.0
Current Assets
+ Inventories	49.4	50.0	64.1
+ Trade Receivables	31.6	13.2	11.4
+ Cash & Cash Equivalents	0.2	0.3	16.7
+ Other Bank Balances	0.2	0.4	0.4
+ Short-term Loans	0.1	0.0	0.0
+ Other Current Financial Assets	6.7	3.5	0.0
Current Financial Assets	38.8	17.4	28.5
+ Other Current Assets	—	0.0	6.3
Total Current Assets	88.2	67.4	98.8
Total Assets	116.9	94.5	124.8
Equity
+ Equity Share Capital	9.2	9.2	19.2
+ Other Equity / Reserves	25.5	5.4	26.4
Equity — Owners of Parent	34.7	14.6	45.6
Total Equity	34.7	14.6	45.6
Liabilities
+ Borrowings — Non-current	3.9	3.8	10.2
Non-current Financial Liabilities	3.9	3.8	10.2
+ Provisions — Non-current	0.8	0.8	0.4
+ Deferred Tax Liabilities	1.5	0.9	1.3
Non-current Liabilities	6.2	5.5	11.9
+ Borrowings — Current	40.4	36.3	35.1
+ Trade Payables	32.3	33.6	25.3
+ Other Current Financial Liab	0.4	0.1	0.4
Current Financial Liabilities	73.1	69.9	60.9
+ Provisions — Current	0.5	0.4	0.1
+ Current Tax Liabilities	0.1	0.0	0.0
+ Other Current Liabilities	2.3	4.0	6.3
Current Liabilities	76.0	74.4	67.3
Total Liabilities	82.1	79.9	79.2
Total Equity & Liabilities	116.9	94.5	124.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	6.2	9.7
+ Dues to Other Creditors — Current	—	27.4	15.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.